IME West Concluded with Nearly 11,500 Attendees and 1,400+ Exhibitors at the 2022 Expo
Highly qualified audience with 50% of registrants holding C-suite or executive-level positions Registered guests benefit…
Highly qualified audience with 50% of registrants holding C-suite or executive-level positions Registered guests benefit…
TORONTO–(BUSINESS WIRE)–Canadian Pension Plans experienced a pullback in investment returns during the first quarter of…
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA assigns preliminary ratings to six classes of mortgage-backed notes from New Residential…
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA releases its auto loan ABS indices for March 2022. March remittance reports…
New York City charter schools adopt PowerSchool Unified Classroom® Schoology Learning and PowerSchool Unified Classroom®…
Lincoln Prairie by Del Webb will offer single-family ranch homes and resort-style amenities for 55+…
● Fireside Chat with B. Riley Research Scheduled for Thursday, April 28th, at 10:00 AM…
Anne Fitzpatrick Donahue assumes role in Greater New York NEW YORK–(BUSINESS WIRE)–Northern Trust has appointed…
Trusted Capital Markets Partner Bolsters Client-Facing Teams with New Hires and Promotions SAN DIEGO–(BUSINESS WIRE)–Mortgage…
Former Fieldpoint Private VP Joins the Firm as Vice President and Senior Portfolio Consultant NEW…
LAKE FOREST, Ill., April 22, 2022 (GLOBE NEWSWIRE) — Assertio Holdings, Inc. (“Assertio” or the…
Part 1: A New Way to Kill Tumors–IO102-IO103 Phase 3 Trial in Combination with Anti-PD-1…
HOUSTON, April 22, 2022 (GLOBE NEWSWIRE) — Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX), a clinical-stage biopharmaceutical…
Additional data collection and analysis reconfirms confidence in New Drug Application for Treosulfan NDA resubmission…
JERSEY CITY, N.J., April 22, 2022 (GLOBE NEWSWIRE) — SCYNEXIS, Inc. (Nasdaq: SCYX) today announced…
Elects Mr. Quinton Oswald and Dr. Susan Orr, deeply experienced Ophthalmology Executives, at a General Meeting of Shareholders MELBOURNE, Australia,…
SINGAPORE and ISELIN, N.J., April 22, 2022 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK),…
Philadelphia, PA, April 22, 2022 (GLOBE NEWSWIRE) — Vallon Pharmaceuticals, Inc. (NASDAQ: VLON), (“Vallon” or…
Data reinforce findings from previous analyses demonstrating oral ibrexafungerp’s potential to combat difficult-to-treat and refractory…
REDWOOD CITY, Calif., April 22, 2022 (GLOBE NEWSWIRE) — Jasper Therapeutics, Inc. (NASDAQ: JSPR), a…